Your SlideShare is downloading. ×
Hipertensão arterial referencias - MS
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Hipertensão arterial referencias - MS

1,747
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,747
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Referências bibliográficas As referências bibliográficas referentes a este informe podem ser encontradas no site http://anvisa.gov.br>>Regulação Econômica>>Boletim Saúde e Economia 1. MION JR., Decio et al . IV Diretrizes Brasileiras de Hipertensão Arterial. Arq. Bras. Cardiol., São Paulo, 2010 . Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066782X2004001000001&lng=en&nrm=iso>. 2. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Hipertensão arterial sistêmica para o Sistema Único de Saúde. Brasília; 2006. Disponível em:<http://bvsms.saude.gov.br/bvs/publicacoes/caderno_atencao_basica15.pdf>. 3. Sociedade Brasileira de Cardiologia. Tratar a pressão alta é um ato de fé na vida. Disponível em: <http://bvsms.saude.gov.br/bvs/publicacoes/cartilha_pressao_fe_vida.pdf>. 4. Brasil. Ministério da Saúde. Pratique Saúde contra a Hipertensão Arterial. Disponível em: <http://portal.saude.gov.br/portal/saude/visualizar_texto.cfm?idtxt=23616&janel a=1>. 5. Ministério do Planejamento, Orçamento e Gestão. Instituto Brasileiro de Geografi a e Estatística. Diretoria de Pesquisas. Coordenação de População e Indicadores Sociais. Estudos e Pesquisas. Informação Demográfica e Socioeconômica número 25 - Indicadores Sociodemográficos e de Saúde no Brasil. Rio e Janeiro; 2009. Disponível em: <http://www.ibge.gov.br/home/estatistica/populacao/indic_sociosaude/2009/indi csaude.pdf>. 6. GUS, Iseu et al. Prevalência, reconhecimento e controle da hipertensão arterial sistêmica no estado do Rio Grande do Sul. Arq. Bras. Cardiol., São Paulo, v. 83 (5), Nov. 2004. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066782X2004001700009&lng=en&nrm=iso>. 7. National Heart Lung and Blood Institute. National Institutes of Health. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - Complete Report. Disponível em: <http://www.nhlbi.nih.gov/guidelines/hypertension/> 8. National Institute for Health and Clinical Excellence. Hypertension Management in adults in primary care: pharmacological update. Disponível em: <http://www.nice.org.uk/Guidance/CG34> 9. SALVETTI, Antônio; GHIADONI, Lorenzo. Guidelines for Antihypertensive Treatment: An Update after the ALLHAT Study. J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S51-4. Disponível em: <http://jasn.asnjournals.org/cgi/content/full/15/1_suppl/S51>. 10. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 Dec 18; 288(23):2981-97.
  • 2. 11. Heidenreich, Paul A et al. Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Gen Intern Med. 2008 May; 23(5): 509–516. 12. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:665. 13. Baguet JP, Legallicier B, Auquier P, Robitail S. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.Clin Drug Investig. 2007; 27(11):735-53.